The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
BACKGROUND: Mesenchymal stem cells (MSCs) are considered the best candidate in stem cells therapy due to their multipotent differentiation ability, low expression of co-stimulatory molecules (CD80, CD86, CD34 and HLA-II) and immunosuppression effects on in vivo immune responses. MSCs were now widely...
Guardado en:
Autores principales: | Zhang,Li, Liu,Dan, Pu,Dan, Wang,Yanwen, Li,Li, He,Yanqi, Li,Yalun, Li,Lei, Li,Weimin |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2015
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602015000100006 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Umbilical artery thrombosis diagnosed at different gestational ages and fetal outcomes: a case series
por: Jing Wei, et al.
Publicado: (2021) -
Effects of Curcumin on High Glucose-Induced Epithelial-to-Mesenchymal Transition in Renal Tubular Epithelial Cells Through the TLR4-NF-κB Signaling Pathway
por: Liu X, et al.
Publicado: (2021) -
Examining immune arms in mice immunized with site-specific influenza virus mutants
por: S. G. Markushin, et al.
Publicado: (2020) -
Aeromonas hydrophila infection induces Toll-like receptor 2 (tlr2) and associated downstream signaling in Indian catfish, Clarias magur (Hamilton, 1822)
por: Chinmayee Muduli, et al.
Publicado: (2021) -
Protective effects of umbilical cord mesenchymal stem cell exosomes in a diabetic rat model through live retinal imaging
por: Yan Fu, et al.
Publicado: (2021)